Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.

Brieghel C, da Cunha-Bang C, Yde CW, Schmidt AY, Kinalis S, Nadeu F, Andersen MA, Jacobsen LO, Andersen MK, Pedersen LB, Delgado J, Baumann T, Mattsson M, Mansouri L, Rosenquist R, Campo E, Nielsen FC, Niemann CU.

Clin Cancer Res. 2020 Jan 9. pii: clincanres.4158.2018. doi: 10.1158/1078-0432.CCR-18-4158. [Epub ahead of print]

PMID:
31919133
2.

A monoclonal antibody recognizing a new epitope on CD81 inhibits T-cell migration without inducing cytokine production.

Hasezaki T, Yoshima T, Mattsson M, Särnefält A, Takubo K.

J Biochem. 2019 Dec 3. pii: mvz103. doi: 10.1093/jb/mvz103. [Epub ahead of print]

PMID:
31794019
3.

Special Issue: "Electric, Magnetic, and Electromagnetic Fields in Biology and Medicine: From Mechanisms to Biomedical Applications".

Scarfì MR, Mattsson MO, Simkó M, Zeni O.

Int J Environ Res Public Health. 2019 Nov 18;16(22). pii: E4548. doi: 10.3390/ijerph16224548.

4.

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.

Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, Malcovati L, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, Zink A, Fuchs D, Kilbertus A, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Niederwieser D, Breynaert C, Várkonyi J, Kennedy V, Lortholary O, Jakob T, Hermine O, Rossignol J, Arock M, Gotlib J, Valent P, Sperr WR.

Leukemia. 2019 Nov 18. doi: 10.1038/s41375-019-0632-4. [Epub ahead of print]

PMID:
31740811
5.

Rapid and repeatable host plant shifts drive reproductive isolation following a recent human-mediated introduction of the apple maggot fly, Rhagoletis pomonella.

Hood GR, Powell THQ, Doellman MM, Sim SB, Glover M, Yee WL, Goughnour RB, Mattsson M, Schwarz D, Feder JL.

Evolution. 2020 Jan;74(1):156-168. doi: 10.1111/evo.13882. Epub 2019 Nov 28.

PMID:
31729753
6.

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study.

Mattsson M, Sandin F, Kimby E, Höglund M, Glimelius I.

Am J Hematol. 2020 Feb;95(2):E36-E38. doi: 10.1002/ajh.25681. Epub 2019 Nov 26. No abstract available.

PMID:
31725930
7.

Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz.

Mattsson MO, Simkó M.

Med Devices (Auckl). 2019 Sep 12;12:347-368. doi: 10.2147/MDER.S214152. eCollection 2019.

8.

5G Wireless Communication and Health Effects-A Pragmatic Review Based on Available Studies Regarding 6 to 100 GHz.

Simkó M, Mattsson MO.

Int J Environ Res Public Health. 2019 Sep 13;16(18). pii: E3406. doi: 10.3390/ijerph16183406. Review.

9.

Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes.

Ljungars A, Svensson C, Carlsson A, Birgersson E, Tornberg UC, Frendéus B, Ohlin M, Mattsson M.

Front Pharmacol. 2019 Jul 30;10:847. doi: 10.3389/fphar.2019.00847. eCollection 2019.

10.

Understanding the Multidimensional Nature of Student Engagement During the First Year of Higher Education.

Korhonen V, Mattsson M, Inkinen M, Toom A.

Front Psychol. 2019 May 10;10:1056. doi: 10.3389/fpsyg.2019.01056. eCollection 2019.

11.

Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis.

Grootens J, Ungerstedt JS, Ekoff M, Rönnberg E, Klimkowska M, Amini RM, Arock M, Söderlund S, Mattsson M, Nilsson G, Dahlin JS.

EBioMedicine. 2019 May;43:150-158. doi: 10.1016/j.ebiom.2019.03.089. Epub 2019 Apr 8.

12.

Group-based trajectory modelling for BMI trajectories in childhood: A systematic review.

Mattsson M, Maher GM, Boland F, Fitzgerald AP, Murray DM, Biesma R.

Obes Rev. 2019 Jul;20(7):998-1015. doi: 10.1111/obr.12842. Epub 2019 Apr 3. Review.

PMID:
30942535
13.

Network models of driver behavior.

Mattsson MT.

PeerJ. 2019 Jan 10;6:e6119. doi: 10.7717/peerj.6119. eCollection 2019.

14.
15.

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.

Winqvist M, Andersson PO, Asklid A, Karlsson K, Karlsson C, Lauri B, Lundin J, Mattsson M, Norin S, Sandstedt A, Rosenquist R, Späth F, Hansson L, Österborg A; Swedish CLL Group.

Haematologica. 2019 May;104(5):e208-e210. doi: 10.3324/haematol.2018.198820. Epub 2018 Dec 4. No abstract available.

16.

First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.

Sylvan SE, Asklid A, Johansson H, Klintman J, Bjellvi J, Tolvgård S, Kimby E, Norin S, Andersson PO, Karlsson C, Karlsson K, Lauri B, Mattsson M, Sandstedt AB, Strandberg M, Österborg A, Hansson L.

Haematologica. 2019 Apr;104(4):797-804. doi: 10.3324/haematol.2018.200204. Epub 2018 Nov 22.

17.

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.

Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, David Fuchs, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR; Study Group of the European Competence Network on Mastocytosis (ECNM).

J Allergy Clin Immunol Pract. 2019 Jan;7(1):81-87. doi: 10.1016/j.jaip.2018.09.024. Epub 2018 Nov 8. Review.

PMID:
30416055
18.

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Baliakas P, Moysiadis T, Hadzidimitriou A, Xochelli A, Jeromin S, Agathangelidis A, Mattsson M, Sutton LA, Minga E, Scarfò L, Rossi D, Davis Z, Villamor N, Parker H, Kotaskova J, Stalika E, Plevova K, Mansouri L, Cortese D, Navarro A, Delgado J, Larrayoz M, Young E, Anagnostopoulos A, Smedby KE, Juliusson G, Sheehy O, Catherwood M, Strefford JC, Stavroyianni N, Belessi C, Pospisilova S, Oscier D, Gaidano G, Campo E, Haferlach C, Ghia P, Rosenquist R, Stamatopoulos K; European Research Initiative on CLL (ERIC).

Haematologica. 2019 Feb;104(2):360-369. doi: 10.3324/haematol.2018.195032. Epub 2018 Sep 27.

19.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Emruli VK, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M.

NPJ Precis Oncol. 2018 Sep 3;2:18. doi: 10.1038/s41698-018-0061-2. eCollection 2018.

20.

Editorial: Effects of Combined EMF Exposures and Co-exposures.

Mattsson MO, Zeni O, Simkó M, Scarfì MR.

Front Public Health. 2018 Aug 20;6:230. doi: 10.3389/fpubh.2018.00230. eCollection 2018. No abstract available.

21.

Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patients.

Wass L, Grankvist A, Mattsson M, Gustafsson H, Krogfelt K, Olsen B, Nilsson K, Mårtensson A, Quarsten H, Henningsson AJ, Wennerås C.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1673-1678. doi: 10.1007/s10096-018-3298-3. Epub 2018 Jun 14.

22.

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

Primo D, Scarfò L, Xochelli A, Mattsson M, Ranghetti P, Espinosa AB, Robles A, Gorrochategui J, Martínez-López J, de la Serna J, González M, Gil AC, Anguita E, Iraheta S, Munugalavadla V, Quéva C, Tannheimer S, Rosenquist R, Stamatopoulos K, Ballesteros J, Ghia P.

Oncotarget. 2018 May 25;9(40):26019-26031. doi: 10.18632/oncotarget.25419. eCollection 2018 May 25.

23.

Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis.

Maher GM, O'Keeffe GW, Kearney PM, Kenny LC, Dinan TG, Mattsson M, Khashan AS.

JAMA Psychiatry. 2018 Aug 1;75(8):809-819. doi: 10.1001/jamapsychiatry.2018.0854.

24.

Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity.

Rosado MM, Simkó M, Mattsson MO, Pioli C.

Front Public Health. 2018 Mar 26;6:85. doi: 10.3389/fpubh.2018.00085. eCollection 2018. Review.

25.

Consensus on core phenomena and statements describing Basic Body Awareness Therapy within the movement awareness domain in physiotherapy.

Skjaerven LH, Mattsson M, Catalan-Matamoros D, Parker A, Gard G, Gyllensten AL.

Physiother Theory Pract. 2019 Jan;35(1):80-93. doi: 10.1080/09593985.2018.1434578. Epub 2018 Feb 26.

PMID:
29482403
26.

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Baliakas P, Mattsson M, Hadzidimitriou A, Minga E, Agathangelidis A, Sutton LA, Scarfo L, Davis Z, Yan XJ, Plevova K, Sandberg Y, Vojdeman FJ, Tzenou T, Chu CC, Veronese S, Mansouri L, Smedby KE, Giudicelli V, Nguyen-Khac F, Panagiotidis P, Juliusson G, Anagnostopoulos A, Lefranc MP, Trentin L, Catherwood M, Montillo M, Niemann CU, Langerak AW, Pospisilova S, Stavroyianni N, Chiorazzi N, Oscier D, Jelinek DF, Shanafelt T, Darzentas N, Belessi C, Davi F, Ghia P, Rosenquist R, Stamatopoulos K.

Haematologica. 2018 Apr;103(4):e158-e161. doi: 10.3324/haematol.2017.182634. Epub 2017 Dec 21. No abstract available.

27.

Cellular Response to ELF-MF and Heat: Evidence for a Common Involvement of Heat Shock Proteins?

Zeni O, Simkó M, Scarfi MR, Mattsson MO.

Front Public Health. 2017 Oct 18;5:280. doi: 10.3389/fpubh.2017.00280. eCollection 2017. Review.

28.

Natural IgM antibodies in the immune defence against neoehrlichiosis.

Wennerås C, Goldblatt D, Zancolli M, Mattsson M, Wass L, Hörkkö S, Rosén A.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):809-816. doi: 10.1080/23744235.2017.1347815. Epub 2017 Jul 6.

PMID:
28682152
29.

Identification of Host Fruit Volatiles from Snowberry (Symphoricarpos albus), Attractive to Rhagoletis zephyria Flies from the Western United States.

Cha DH, Olsson SB, Yee WL, Goughnour RB, Hood GR, Mattsson M, Schwarz D, Feder JL, Linn CE Jr.

J Chem Ecol. 2017 Feb;43(2):188-197. doi: 10.1007/s10886-016-0814-8. Epub 2017 Jan 11.

PMID:
28078623
30.

The changing face of nanomaterials: Risk assessment challenges along the value chain.

Mattsson MO, Simkó M.

Regul Toxicol Pharmacol. 2017 Mar;84:105-115. doi: 10.1016/j.yrtph.2016.12.008. Epub 2016 Dec 18. Review.

PMID:
27998719
31.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2016 Jun;5(6):845. doi: 10.5966/sctm.2015-0021erratum. No abstract available.

32.

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.

Winqvist M, Asklid A, Andersson PO, Karlsson K, Karlsson C, Lauri B, Lundin J, Mattsson M, Norin S, Sandstedt A, Hansson L, Österborg A.

Haematologica. 2016 Dec;101(12):1573-1580. Epub 2016 May 19.

33.

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2.

Bhoi S, Ljungström V, Baliakas P, Mattsson M, Smedby KE, Juliusson G, Rosenquist R, Mansouri L.

Epigenetics. 2016 Jun 2;11(6):449-55. doi: 10.1080/15592294.2016.1178432. Epub 2016 Apr 29.

34.
35.

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas P, Mattsson M, Stamatopoulos K, Rosenquist R.

J Intern Med. 2016 Apr;279(4):347-57. doi: 10.1111/joim.12455. Epub 2015 Dec 28. Review.

36.

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi S, Baliakas P, Cortese D, Mattsson M, Engvall M, Smedby KE, Juliusson G, Sutton LA, Mansouri L.

Haematologica. 2016 Feb;101(2):e63-5. doi: 10.3324/haematol.2015.136440. Epub 2015 Nov 20. No abstract available.

37.

Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.

Simkó M, Tischler S, Mattsson MO.

Int J Mol Sci. 2015 Nov 2;16(11):26211-36. doi: 10.3390/ijms161125954.

38.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K.

Stem Cells Transl Med. 2015 Oct;4(10):1199-213. doi: 10.5966/sctm.2015-0021. Epub 2015 Aug 18. Erratum in: Stem Cells Transl Med. 2016 Jun;5(6):845.

39.

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.

Otto C, Särnefält A, Ljungars A, Wolf S, Rohde-Schulz B, Fuchs I, Schkoldow J, Mattsson M, Vonk R, Harrenga A, Freiberg C.

Endocrinology. 2015 Nov;156(11):4365-73. doi: 10.1210/en.2015-1277. Epub 2015 Aug 18.

PMID:
26284426
40.

The impact of hypnotic suggestions on reaction times in continuous performance test in adults with ADHD and healthy controls.

Virta M, Hiltunen S, Mattsson M, Kallio S.

PLoS One. 2015 May 11;10(5):e0126497. doi: 10.1371/journal.pone.0126497. eCollection 2015.

41.

Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference.

Dür M, Coenen M, Stoffer MA, Fialka-Moser V, Kautzky-Willer A, Kjeken I, Drăgoi RG, Mattsson M, Boström C, Smolen J, Stamm TA.

Health Qual Life Outcomes. 2015 Feb 25;13:27. doi: 10.1186/s12955-015-0214-8.

42.

Measurement invariance of the Driver Behavior Questionnaire across samples of young drivers from Finland and Ireland.

Mattsson M, O'Brien F, Lajunen T, Gormley M, Summala H.

Accid Anal Prev. 2015 May;78:185-200. doi: 10.1016/j.aap.2015.02.017. Epub 2015 Mar 19.

PMID:
25797304
43.

Depth, soil type, water table, and site effects on microbial community composition in sediments of pesticide-contaminated aquifer.

Mattsson MK, Liu X, Yu D, Kontro MH.

Environ Sci Pollut Res Int. 2015 Jul;22(13):10263-79. doi: 10.1007/s11356-015-4224-1. Epub 2015 Feb 24.

PMID:
25703619
44.

Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures. A multicentre European qualitative study and literature review.

Mattsson M, Boström C, Mihai C, Stöcker J, Geyh S, Stummvoll G, Gard G, Möller B, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Distler O, Smolen JS, Stamm TA.

Eur J Phys Rehabil Med. 2015 Aug;51(4):405-21. Epub 2015 Jan 9. Review.

45.
46.

[Danish studies of acute treatment after initiation of emergency departments].

Mattsson MS, Jørsboe H.

Ugeskr Laeger. 2014 Jul 21;176(30):1396-8. Review. Danish.

PMID:
25292231
47.
48.

EMF monitoring-concepts, activities, gaps and options.

Dürrenberger G, Fröhlich J, Röösli M, Mattsson MO.

Int J Environ Res Public Health. 2014 Sep 11;11(9):9460-79. doi: 10.3390/ijerph110909460. Review.

49.

Interactions between nanosized materials and the brain.

Simkó M, Mattsson MO.

Curr Med Chem. 2014;21(37):4200-14. Review.

50.

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Höper L, Sakiniene E, Trysberg E, Stenson M, Fehr J, Pekova S, Bogdan C, Bloemberg G, Wennerås C.

Clin Infect Dis. 2014 Jun;58(12):1716-22. doi: 10.1093/cid/ciu189. Epub 2014 Mar 18.

Supplemental Content

Loading ...
Support Center